Ron Pedersen

2.4k total citations
55 papers, 1.8k citations indexed

About

Ron Pedersen is a scholar working on Rheumatology, Immunology and Pharmacology. According to data from OpenAlex, Ron Pedersen has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Rheumatology, 14 papers in Immunology and 11 papers in Pharmacology. Recurrent topics in Ron Pedersen's work include Rheumatoid Arthritis Research and Therapies (32 papers), Spondyloarthritis Studies and Treatments (19 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Ron Pedersen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (32 papers), Spondyloarthritis Studies and Treatments (19 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Ron Pedersen collaborates with scholars based in United States, Netherlands and France. Ron Pedersen's co-authors include Bonnie Vlahos, B Freundlich, Jonathan Davidson, Dan J. Stein, David S. Baldwin, Désirée van der Heijde, Jack F. Bukowski, Maxime Dougados, Jeff Musgnung and Joseph Wajdula and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Ron Pedersen

54 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ron Pedersen United States	25	1.0k	558	417	233	211	55	1.8k
Kenneth N. Schikler United States	20	269 0.3×	161 0.3×	388 0.9×	122 0.5×	257 1.2×	52	1.7k
Pedro Zarco Spain	26	1.1k 1.0×	679 1.2×	368 0.9×	34 0.1×	74 0.4×	173	2.5k
Enrico Fusaro Italy	22	293 0.3×	181 0.3×	115 0.3×	98 0.4×	199 0.9×	84	1.2k
Alberto Batticciotto Italy	22	555 0.5×	385 0.7×	209 0.5×	47 0.2×	169 0.8×	66	1.3k
Niki Tsifetaki Greece	23	564 0.5×	194 0.3×	149 0.4×	68 0.3×	56 0.3×	45	1.5k
Ljudmila Stojanovich Serbia	23	1.1k 1.1×	598 1.1×	381 0.9×	38 0.2×	27 0.1×	57	2.2k
Natalya Danchenko United States	19	739 0.7×	522 0.9×	75 0.2×	36 0.2×	266 1.3×	62	1.5k
Yusuke Miwa Japan	16	307 0.3×	317 0.6×	114 0.3×	114 0.5×	45 0.2×	67	1.1k
Sofia Pedro United States	16	488 0.5×	111 0.2×	141 0.3×	33 0.1×	43 0.2×	38	954
John J. Calabro United States	18	613 0.6×	154 0.3×	483 1.2×	45 0.2×	496 2.4×	70	1.9k

Countries citing papers authored by Ron Pedersen

Since Specialization

Citations

This map shows the geographic impact of Ron Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Pedersen more than expected).

Fields of papers citing papers by Ron Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Pedersen. The network helps show where Ron Pedersen may publish in the future.

Co-authorship network of co-authors of Ron Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Pedersen. A scholar is included among the top collaborators of Ron Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Pedersen. Ron Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maksymowych, Walter P., Pascal Claudepierre, Manouk de Hooge, et al.. (2024). Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort). The Journal of Rheumatology. 51(5). 462–471.

Dougados, Maxime, Désirée van der Heijde, Wen‐Chan Tsai, et al.. (2020). Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study. Health and Quality of Life Outcomes. 18(1). 4–4. 8 indexed citations

Dougados, Maxime, Walter P. Maksymowych, Robert Landewé, et al.. (2018). Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis. Annals of the Rheumatic Diseases. 77(2). 221–227. 33 indexed citations

Hajjaj‐Hassouni, N., et al.. (2018). The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study. Rheumatology and Therapy. 5(2). 437–445. 5 indexed citations

Vlahos, Bonnie, et al.. (2018). Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis. Rheumatology and Therapy. 5(1). 149–158. 1 indexed citations

Chen, Yi‐Hsing, Umut Kalyoncu, Lyndon Llamado, et al.. (2018). Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice. Biologics. Volume 12. 1–9. 7 indexed citations

Sandborn, William J., Julián Panés, Geert D’Haens, et al.. (2018). Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials. Clinical Gastroenterology and Hepatology. 17(8). 1541–1550. 193 indexed citations

Maksymowych, Walter P., Stephanie Wichuk, Maxime Dougados, et al.. (2017). Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis. Annals of the Rheumatic Diseases. 77(1). 78–84. 36 indexed citations

Wiland, Piotr, Jean Dudler, Douglas J. Veale, et al.. (2016). The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis. The Journal of Rheumatology. 43(7). 1268–1277. 10 indexed citations

10.

Maksymowych, Walter P., Maxime Dougados, Désirée van der Heijde, et al.. (2015). Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. Annals of the Rheumatic Diseases. 75(7). 1328–1335. 80 indexed citations

11.

Bae, Sang‐Cheol, Chi Chiu Mok, Rezaul Karim Khandker, et al.. (2013). Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis. BMC Musculoskeletal Disorders. 14(1). 13–13. 38 indexed citations

12.

Gelenberg, Alan J., David L. Dünner, Anthony J. Rothschild, et al.. (2013). Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study. The Journal of Nervous and Mental Disease. 201(4). 266–273. 14 indexed citations

13.

Rahav, Galia, Edward T. Zito, David Gardiner, et al.. (2012). A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. BMC Infectious Diseases. 12(1). 297–297. 27 indexed citations

14.

Dunlop, Boadie W., Thomas Li, Susan G. Kornstein, et al.. (2010). Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder. Journal of Psychiatric Research. 45(1). 96–103. 43 indexed citations

15.

Emery, Paul, Patrick Durez, F C Breedveld, et al.. (2008). Clinical remission, radiographic non-progression, and normalized function with the combination of etanercept and methotrexate in the treatment of early active rheumatoid arthritis: 1-year results of the COMET trial. Digital Access to Libraries. 58(9). 1 indexed citations

16.

Davidson, Jonathan, David S. Baldwin, Dan J. Stein, et al.. (2008). Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor–Davidson Resilience Scale. International Clinical Psychopharmacology. 23(5). 299–303. 36 indexed citations

17.

Heijde, Désirée van der, Cătălin Codreanu, E. Martín Mola, et al.. (2008). Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. Annals of the Rheumatic Diseases. 68(7). 1113–1118. 14 indexed citations

18.

Riel, Piet L. C. M. van, et al.. (2007). Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial. Annals of the Rheumatic Diseases. 67(8). 1104–1110. 32 indexed citations

19.

Heijde, D. van der, et al.. (2007). The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. Annals of the Rheumatic Diseases. 67(2). 182–188. 28 indexed citations

20.

Davidson, Jonathan, David S. Baldwin, Dan J. Stein, et al.. (2006). Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release. Archives of General Psychiatry. 63(10). 1158–1158. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact